This site is intended for health professionals only

Editor’s pick

Leading Dengue and TB scientists in talks about clinical trials
Leading Dengue and TB scientists in talks about clinical trials
Novartis to review QAB149 COPD drug
Novartis to review QAB149 COPD drug
Blood cancer treatment approved
Blood cancer treatment approved
Duel treatment slows joint damage
Duel treatment slows joint damage
London centre for cancer research
London centre for cancer research
GSK withdraws Zunrisa application
GSK withdraws Zunrisa application
Call to protect local pharmacies
Call to protect local pharmacies
Duel prostate-treatment success
Duel prostate-treatment success
Urate-Parkinson’s link studied
Urate-Parkinson’s link studied
Onyx acquires Proteolix cancer drug
Onyx acquires Proteolix cancer drug
New prostate cancer treatment close
New prostate cancer treatment close
Novartis enters into agreement for exclusive US and Canadian rights to Fanapt
Novartis enters into agreement for exclusive US and Canadian rights to Fanapt
1 … 107 108 109 110 111 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x